Dr TAN See Leng
Dr TAN See Leng
Managing Directorand CEO, IHH Healthcare Berhad
Group CEO and Managing Director, Parkway Pantai Limited
Dr Tan See Leng provides strategic direction and leadership for overall operations within IHH Healthcare (IHH) and its largest operating subsidiary, Parkway Pantai. He is an Executive Director of IHH since 2012 and has held the position of Managing Director and CEO since January 2014.
Under his stewardship, IHH has grown its footprint to more than 50 hospitals in 10 countries worldwide, focusing on accretive opportunities in emerging markets particularly the high-intensity quaternary segment. It delivers superior patient care across Asia through its key operating units – Parkway Pantai, Acibadem Healthcare Group and IMU Health.
Dr Tan joined Parkway in 2004 as Chief Operating Officer of Mount Elizabeth Hospital and rose rapidly through the ranks. Following the restructuring of the Group in 2011, he assumed his current position as the Group CEO and Managing Director of Parkway Pantai. In recognition of his leadership in steering IHH to becoming a highly-valued global healthcare organisation, Dr Tan was named Asia Innovator of the Year at the 14th CNBC Asia Business Leaders Awards (ABLA) 2015 and Best Executive in Malaysia at the 2016 Asiamoney Best Managed Companies Awards. In 2017, he won the ABLA Corporate Social Responsibility Award.
Dr Tan has over 25 years of experience in the healthcare industry. At the age of 27, he founded a private primary healthcare group and subsequently developed it to the second largest primary healthcare group in Singapore before successfully selling the company to one of the leading global health-plan provider. Over the years, he has held numerous ministerial advisory and medical committee appointments, and has most recently served on the Singapore Ministry of Health’s MediShield Life Review Committee.
A passionate supporter of improving healthcare provision through innovations and private-public collaboration, Dr Tan has guest lectured at the Harvard Business School’s healthcare management seminar series. He also provided advisory inputs as an expert panel member for Department of Health, National Health Services (United Kingdom). Dr Tan maintains active involvement in academia through board memberships and appointments such as Adjunct Assistant Professor of Duke-NUS Graduate Medical School Singapore, Office of Education and Advisory Board of Lee Kong Chian School of Business at Singapore Management University. On the business front, he regularly represents regional business leadership on International and Regional Business Councils. He is often featured as a thought leader in international and regional business journals and magazines.